Analytical Chemistry - Platform and Mass Spectrometry principal scientist
Leads the strategic modernisation of analytical chemistry platforms at GSK to support emerging therapeutic modalities such as divalent small molecules, antibody-drug conjugates, and oligonucleotides. Provides hands-on scientific leadership, integrates high-throughput workflows, and drives capability evolution across discovery and development. Works across matrix teams to align platform strategy with pipeline needs and long-term innovation goals.